Clinical Trial Update: Radiation Therapy, Arsenic Trioxide, and Temozolomide in Treating Patients With Newly Diagnosed High-Grade Glioma [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the combination of radiation therapy, arsenic trioxide, and temozolomide in newly diagnosed high-grade glioma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma
• High-grade Glioma

Drugs mentioned

• Temodar (Temozolomide)
• Trisenox (arsenic trioxide)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Brain and Central Nervous System Tumors | Phase 1 | Status: COMPLETED